Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Watch
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Judith C. McCaffrey, MD

Advertisement

Articles by Judith C. McCaffrey, MD

Prognostic Significance of Post-Treatment PET/CT Following Salvage Re-irradiation of Head and Neck Cancers

ByTawee Tanvetyanon, MD, MPH,Tapan A. Padhya, MD,Judith C. McCaffrey, MD,Julie A. Kish, MD,Jimmy J. Caudell, MD, PhD,Andy Trotti, MD,Edward A. Eikman, MD
March 7th 2016

Researchers explored the prognostic significance of PET/CT following re-irradiation in patients with head and neck cancer.

Advertisement

Latest Updated Articles

  • Prognostic Significance of Post-Treatment PET/CT Following Salvage Re-irradiation of Head and Neck Cancers
    Prognostic Significance of Post-Treatment PET/​CT Following Salvage Re-irradiation of Head and Neck Cancers

    March 7th 2016



Advertisement
Advertisement

Trending on OncLive

1

FDA Approves Daraxonrasib for Metastatic Pancreatic Ductal Adenocarcinoma

2

Dr Reiss Binder on the FDA Approval of Daraxonrasib for Metastatic PDAC

3

ASCO Issues Warning Regarding Ifosfamide Shortage for Cancer Care

4

Dr Ayanambakkam on the Safety of Darlifarnib Plus Cabozantinib in RCC KD

5

Dr Borate on Efficacy Data for Shorter Venetoclax-Plus-Azacitidine Dosing in AML

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us